Navigation Links
Terumo to simultaneously evaluate Misago self-expanding stent system in the United States and Japan
Date:5/12/2010

SOMERSET, NJ (May 12, 2010) Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced it has received an investigational device exemption (IDE) conditional approval from the U.S. Food & Drug Administration (FDA) for its Occlusive/Stenotic Peripheral Artery Revascularization Study (OSPREY) in the U.S., which will evaluate the safety and effectiveness of the MISAGO Self-expanding Stent System for use in the superficial femoral artery (SFA). This marks the company's first U.S. clinical trial for a premarket approval (PMA) device. A unique feature of the clinical trial is that it will simultaneously enroll patients in the U.S. and Japan. Referred to as "Medical Device Collaborative Consultation and Review of Premarketing Applications" under the larger "Harmonization by Doing" (HBD) initiative, Terumo's trial was selected as one of two projects to pilot this approach, which is intended to shorten the gap between product approvals in these two significant world healthcare markets.

HBD is an international effort to develop global clinical trials and address regulatory barriers that may be impediments to timely device approvals. This process is a cooperative effort to move both Japan and the U.S. toward international regulatory harmonization. The HBD initiative is a pilot project launched in December 2003 that seeks regulatory convergence between FDA and MHLW-PMDA (Japan's regulatory bodies). The learning obtained in the "proof of concept" trials will assist both regulatory bodies in streamlining the clinical trial process for faster approvals in both countries, as well as promote the idea of global trials for purposes of collecting better data. In this pilot HBD approach, the products will be submitted for review and approval at the same time.

"I believe this approach to shorten the time for new product approvals between the U.S. and Japan is critical and exciting," said Takao Ohki, MD, Chairman and Professor, D
'/>"/>

Contact: Robert Murphy
rmurphy@storchmurphy.com
908-276-0777
The Storch Murphy Group
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need
2. Terumo Medical Corporation Announces its Program for the Global Embolization Symposium and Technologies (GEST) Meeting
3. Guinness World Records(R) Attempt For Most People Kissing Simultaneously to Take Place This New Years Eve
4. Scientific panel evaluates soy infant formula safety
5. Brandeis studies evaluate visionary approach to improving eyesight
6. VHGI: VHGI Gold Targets Candidates to Fill Key Advisory Board Position to Evaluate International Mining Acquisitions; Internet Town Hall Meeting Details Emerge, Kitco Gold Coverage Initiated
7. CDC Awards Abt Associates Additional Contracts to Evaluate Effectiveness of H1N1 Vaccine
8. Mathematical model can help communities better evaluate sex offender policies
9. Study evaluates costs and benefits of new chemotherapy drugs
10. Study evaluates costs and benefits associated with new colon cancer therapies
11. Study evaluates importance of timeliness of care in breast cancer diagnosis and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Terumo to simultaneously evaluate Misago self-expanding stent system in the United States and Japan
(Date:6/19/2013)... After investing efforts for months in ... formally announced the launch of database integration for the ... latest entry in the list of extraordinary vehicles lined ... redesigned 2012 Nissan NV is all ready to get ... , Provided with two high power capable engines, the ...
(Date:6/19/2013)... Audibel Hearing Center is pleased ... patients, the A2 with Multiflex Tinnitus Technology. Tinnitus ... in the ears. Although bothersome, tinnitus usually isn’t ... , Using their patent-pending Multiflex Tinnitus Technology, the ... sound stimulus that resonates through the patient’s ear. ...
(Date:6/19/2013)... June 19, 2013 According to Vanessa ... abusers called “psychonauts” are creating new designer drugs featuring ... research of published documents and patented formulas. She reported ... & Now on June 4. , “Some of ... They’re never tested on humans. Maybe some of them ...
(Date:6/19/2013)... The Report "Data Center Security Market ... DLP, UTM, IAM, SIEM, DR, ILM); Physical Security ... Advancements, Forecasts & Analysis (2013-2018)", defines and segments ... sub-segments with in-depth analysis and forecasting of revenues. ... market with insights into trends, opportunities, and challenges. ...
(Date:6/19/2013)... Tewkesbury, UK (PRWEB) June 19, 2013 ... solutions, is sponsoring today's event, at which it will ... issues, as well as giving further insight into its ... gathering for IT & business professionals specialising in IDM ... wide range of markets including the public sector, banking, ...
Breaking Medicine News(10 mins):Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4
... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...
... be available in pharmacies as over the counter drug ... women to avoid unnecessary pregnancy. The decision was announced// ... the governments decision the minister said, "The step has ... such situations as unprotected sexual exposure, contraceptive accident or ...
... from the Steno Diabetes Center, Denmark has found ... taking //antihypertensive drugs, reduced the chances of developing ... protein in urine of these patients. ... prone to kidney diseases. Supplementation of Spironolactone has ...
... of AIDS and 35 people have died of it in the ... at more than 100 and more than 2,000 full-blown AIDS cases. ... very low awareness in Jharkand. ,Jharkand plans to open ... of HIV spread. This new attempt to open the condom booths ...
... losing their eyesight later in life than non-smokers, says a ... UK with age-related macular degeneration (AMD). Of these, an ... smoking.// ,AMD usually develops after a person reaches ... of the eye. A report by AMD Alliance UK, based ...
... The lancet says that a combination of newer ... procedures.// ,Hypertension is the most important preventable ... the benefits of anti-hypertensive drugs for prevention of ... no individual trial using standard diuretic or Beta-blocker ...
Cached Medicine News:Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2
(Date:6/18/2013)... Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader in ... corporate update in conjunction with its 2013 Annual Meeting of ... p.m. Pacific Time in Carlsbad, CA. ... 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only ... p.m. – 3:15 p.m. Corporate Presentation – Stanley T. ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
... Reportlinker.com announces that a new market research report ... Global Markets for Catheters http://www.reportlinker.com/p0801348/Global-Markets-for-Catheters.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ...   STUDY GOALS AND OBJECTIVES ... in conducting this study was to determine the present ...
...  Experts from PAREXEL International Corporation (NASDAQ: ... will advise biopharmaceutical companies on how to successfully navigate ... Drug Information Association (DIA) 24th Annual EuroMeeting. The meeting ... Copenhagen, Denmark. Consultants from PAREXEL will be ...
Cached Medicine Technology:Global Markets for Catheters 2Global Markets for Catheters 3Global Markets for Catheters 4Global Markets for Catheters 5Global Markets for Catheters 6Global Markets for Catheters 7Global Markets for Catheters 8Global Markets for Catheters 9Global Markets for Catheters 10Global Markets for Catheters 11Global Markets for Catheters 12Global Markets for Catheters 13Global Markets for Catheters 14Global Markets for Catheters 15Global Markets for Catheters 16PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting 2PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting 3PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting 4
Blunt Weitlaner Retractor....
Weitlaner Beckmann retractor, sharp prongs, SS....
Baby Weitlaner retractor, blunt, 4"....
Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....
Medicine Products: